Clinical Trials Sponsored by Spark Therapeutics, Inc.
Total 3046 results
-
Spark Therapeutics, Inc.Recruiting
-
Spark TherapeuticsActive, not recruitingInherited Retinal Dystrophy Due to RPE65 Mutations
-
Spark TherapeuticsCompletedHematologic Diseases | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Gene Therapy | Blood Coagulation Disorder | Gene Transfer | Adeno-Associated Virus (AAV) | Factor VIII (FVIII) | Factor VIII (FVIII)... and other conditionsUnited States
-
Spark TherapeuticsCompletedHematologic Diseases | Hemophilia A | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Blood Coagulation Disorder | Factor VIII DeficiencyUnited States, Australia, Thailand, Canada
-
Spark TherapeuticsActive, not recruitingConfirmed Biallelic RPE65 Mutation-associated Retinal DystrophyUnited States
-
Spark TherapeuticsActive, not recruitingHemophilia AUnited States, Canada, Australia
-
Spark TherapeuticsCompletedHemophilia AUnited States, Australia, Canada, Israel, Thailand
-
Spark TherapeuticsCompletedChoroideremia | CHM (Choroideremia) Gene MutationsUnited States
-
Spark TherapeuticsActive, not recruitingLysosomal Storage Diseases | Glycogen Storage Disease Type II | Glycogen Storage Disease Type 2 | Pompe Disease (Late-onset) | Pompe Disease | LOPD | Acid Maltase DeficiencyUnited States, Canada, Netherlands, France, Denmark, Germany, Italy, United Kingdom
-
Spark TherapeuticsActive, not recruitingLeber Congenital AmaurosisUnited States
-
Spark TherapeuticsCompletedLysosomal Storage Diseases | Glycogen Storage Disease Type 2 | Pompe Disease (Late-onset) | Pompe Disease | LOPD | Acid Maltase DeficiencyUnited States, Italy, United Kingdom, Netherlands, France, Germany
-
Spark TherapeuticsCompleted
-
Spark Neuro Inc.Recruiting
-
Spark Biomedical, Inc.CompletedNovel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid WithdrawalOpioid-use Disorder | Opioid WithdrawalUnited States
-
Spark Biomedical, Inc.CompletedOpioid-use Disorder | Opioid WithdrawalUnited States
-
Spark Therapeutics, Inc.Children's Hospital of Philadelphia; University of IowaActive, not recruitingLeber Congenital Amaurosis | Inherited Retinal Dystrophy Due to RPE65 MutationsUnited States
-
Five Liters, Inc.RecruitingHeavy Menstrual Bleeding | Von Willebrand Disease, Type 1United States
-
Mayo ClinicSpark Neuro Inc.Enrolling by invitationAlzheimer Disease | Mild Cognitive Impairment | Dementia With Lewy Bodies | Normal Control APOE e4 Carriers and NoncarriersUnited States
-
Mayo ClinicSpark Neuro Inc.Completed
-
BlackThorn Therapeutics, Inc.Neumora Therapeutics, Inc.CompletedMajor Depressive DisorderUnited States
-
Sirion Therapeutics, Inc.ReVision Therapeutics, Inc.CompletedGeographic Atrophy | Dry Age Related Macular Degeneration
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.Completed
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPsoriasis | Plaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedTinea Pedis | Tinea CrurisUnited States
-
Therapeutics, Inc.CompletedScalp PsoriasisUnited States
-
Therapeutics, Inc.CompletedAcne VulgarisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPsoriasis | Plaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedA Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)Plaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedTinea PedisUnited States, Puerto Rico
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States, Georgia, Ukraine
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedA Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)Plaque PsoriasisUnited States
-
Roswell Park Cancer InstituteCelldex TherapeuticsCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Refractory Anemia | Blasts 30 Percent or Less of Bone Marrow Nucleated CellsUnited States
-
Spark Biomedical, Inc.Battelle Memorial InstituteNot yet recruitingCognitive Performance | Acute Stress ReactionUnited States
-
Chinook Therapeutics U.S., Inc.Active, not recruitingImmunoglobulin A Nephropathy | IgA NephropathyUnited States, Spain, Taiwan, Hong Kong, China, New Zealand, United Kingdom, Korea, Republic of, Canada, Australia, Germany, France, India, Japan, Argentina, Italy, Brazil, Colombia, Poland, Portugal
-
Millendo Therapeutics US, Inc.TerminatedCongenital Adrenal HyperplasiaSpain, Israel, France, Brazil, Czechia
-
University of CincinnatiSpark Biomedical, Inc.Not yet recruitingOpioid Use Disorder | Posttraumatic Stress DisorderUnited States
-
Cascadian Therapeutics Inc.Celldex TherapeuticsCompletedAdvanced Breast Carcinoma | Advanced Ovarian CarcinomaUnited States
-
Chinook Therapeutics U.S., Inc.Active, not recruitingDiabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport SyndromeUnited States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
-
Millendo Therapeutics US, Inc.TerminatedCushing SyndromeUnited States, United Kingdom
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorAustralia, United States
-
Chinook Therapeutics, Inc. (formerly Aduro)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Axsome Therapeutics, Inc.RecruitingBinge-Eating DisorderUnited States